Stereotaxis Inc Stock Nasdaq
Equities
US85916J1025
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Jul. 01 | Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Completeness Index | CI |
Financials (USD)
Sales 2024 * | 30.4M | Sales 2025 * | 43.6M | Capitalization | 156M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | -15M | EV / Sales 2024 * | 5.13 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.58 x |
P/E ratio 2024 * |
-7.92
x | P/E ratio 2025 * |
-8.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.16% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
David Fischel
CEO | Chief Executive Officer | 57 | 16-09-28 |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 02-12-31 |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
David Fischel
CEO | Chief Executive Officer | 57 | 16-09-28 |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |